Holen Sie sich die Stockscreener-App
4.98
4.18%
0.20
Handel nachbörslich:
5.00
0.02
+0.40%
Schlusskurs vom Vortag:
$4.78
Offen:
$4.77
24-Stunden-Volumen:
79,870
Relative Volume:
0.01
Marktkapitalisierung:
$15.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-37.75M
KGV:
-1.5323
EPS:
-3.25
Netto-Cashflow:
$-30.91M
1W Leistung:
+6.18%
1M Leistung:
-1.58%
6M Leistung:
+1,647%
1J Leistung:
+132.71%
1-Tages-Spanne:
$4.645
$5.02
1-Wochen-Bereich:
$4.43
$5.08
52-Wochen-Spanne:
$0.224
$10.19
Cellectar Biosciences Inc Stock (CLRB) Company Profile
Firmenname
Cellectar Biosciences Inc
Sektor
Branche
Telefon
(608) 441-8120
Adresse
100 CAMPUS DRIVE, FLORHAM PARK, NJ
Vergleichen Sie CLRB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLRB
Cellectar Biosciences Inc
|
4.98 | 15.39M | 0 | -37.75M | -30.91M | -3.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cellectar Biosciences Inc Stock (CLRB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-05 | Fortgesetzt | Ladenburg Thalmann | Buy |
| 2020-07-01 | Eingeleitet | Oppenheimer | Outperform |
| 2020-01-21 | Fortgesetzt | ROTH Capital | Buy |
| 2019-09-13 | Eingeleitet | ROTH Capital | Buy |
| 2016-12-21 | Eingeleitet | Ladenburg Thalmann | Buy |
Cellectar Biosciences Inc Aktie (CLRB) Neueste Nachrichten
How does Cellectar Biosciences Inc. compare to its peers2025 AllTime Highs & Reliable Volume Spike Trade Alerts - khodrobank.com
Will Cellectar Biosciences Inc. see short term momentumOptions Play & Advanced Swing Trade Entry Plans - Newser
Is Cellectar Biosciences Inc. a strong candidate for buy and hold - khodrobank.com
Using AI based signals to follow Cellectar Biosciences Inc.July 2025 Drop Watch & Accurate Intraday Trading Signals - Newser
Real time social sentiment graph for Cellectar Biosciences Inc.2025 Institutional Moves & Community Consensus Picks - Newser
Can Cellectar Biosciences Inc. expand its profit marginsQuarterly Trade Review & Risk Managed Investment Strategies - khodrobank.com
Does Cellectar Biosciences Inc. show high probability of reboundQuarterly Earnings Summary & Weekly Sector Rotation Insights - Newser
How to use a screener to detect Cellectar Biosciences Inc. breakouts2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
How moving averages guide Cellectar Biosciences Inc. trading2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Measuring Cellectar Biosciences Inc.’s beta against major indices2025 Market Sentiment & Free Community Supported Trade Ideas - Newser
Cellectar Biosciences shares fall 1.24% premarket as Oncolytics Biotech Inc. gains FDA approval for breakthrough therapies. - AInvest
Cellectar Biosciences Announces Poster Presentation at AACR Conference on Preclinical Data for Novel Cancer Treatment CLR 121225 - Quiver Quantitative
Cellectar Biosciences Presents Data on CLR 121225 in Poster Presentation at AACR Special Conference on Pancreatic Cancer Research - AInvest
Cellectar Biosciences to Present Data in Poster - GlobeNewswire
Novel Pancreatic Cancer Radio-Conjugate: Cellectar to Present Breakthrough Treatment Data at AACR Conference - Stock Titan
Analyzing drawdowns of Cellectar Biosciences Inc. with statistical toolsJuly 2025 Levels & Reliable Momentum Entry Alerts - Newser
What indicators show strength in Cellectar Biosciences Inc.2025 Performance Recap & Free Expert Approved Momentum Trade Ideas - Newser
How to use Fibonacci retracement on Cellectar Biosciences Inc.July 2025 EndofMonth & Free Growth Oriented Trading Recommendations - Newser
Identifying reversal signals in Cellectar Biosciences Inc.July 2025 Analyst Calls & High Accuracy Trade Alerts - Newser
Statistical indicators supporting Cellectar Biosciences Inc.’s strengthJuly 2025 Update & High Accuracy Swing Entry Alerts - Newser
Aug Macro: How does Cellectar Biosciences Inc. compare to its peersPortfolio Growth Summary & Weekly Chart Analysis and Guides - khodrobank.com
Cellectar Biosciences Inc. stock momentum explainedQuarterly Performance Summary & Daily Chart Pattern Signals - Newser
What is Cellectar Biosciences Inc. s revenue forecast2025 Trading Volume Trends & Fast Moving Stock Trade Plans - khodrobank.com
Why Cellectar Biosciences Inc. stock attracts strong analyst attentionTrade Ideas & Real-Time Price Movement Reports - Newser
Is Cellectar Biosciences Inc. trending in predictive chart modelsEarnings Beat & Weekly High Conviction Trade Ideas - Newser
Cellectar Biosciences shares fall 1.45% after-hours as Oncolytics Biotech Inc. gains regulatory momentum. - AInvest
Building trade automation scripts for Cellectar Biosciences Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Is Cellectar Biosciences Inc. vulnerable to short sellers2025 Market Outlook & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Using fundamentals and technicals on Cellectar Biosciences Inc.Weekly Earnings Recap & Free Expert Approved Momentum Trade Ideas - Newser
Breakthrough Cancer Therapies Fuel Regulatory Momentum as Global Market Expands - The Ritz Herald
Is Cellectar Biosciences Inc. part of any ETF2025 Support & Resistance & Technical Pattern Recognition Alerts - khodrobank.com
Earnings Recap: Is Cellectar Biosciences Inc. vulnerable to short sellersRate Hike & Target Return Focused Stock Picks - khodrobank.com
Will Cellectar Biosciences Inc. outperform during market ralliesEarnings Recap Summary & Community Trade Idea Sharing Platform - khodrobank.com
Is Cellectar Biosciences Inc. backed by strong institutional buyingQuarterly Portfolio Summary & Fast Entry Momentum Trade Alerts - khodrobank.com
Published on: 2025-09-01 21:25:14 - Newser
What is Cellectar Biosciences Inc. s debt to equity ratioQuarterly Market Review & AI Enhanced Trading Signals - خودرو بانک
Short interest data insights for Cellectar Biosciences Inc.Jobs Report & High Accuracy Swing Entry Alerts - Newser
Visualizing Cellectar Biosciences Inc. stock with heatmapsWeekly Trade Recap & Precise Buy Zone Identification - Newser
Cellectar Biosciences Earnings Call: Progress Amid Challenges - TipRanks
Certain Pre-Funded Warrants of Cellectar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 1-SEP-2025. - MarketScreener
Certain Warrants of Cellectar Biosciences, Inc. are subject to a Lock-Up Agreement Ending on 1-SEP-2025. - MarketScreener
Is it time to cut losses on Cellectar Biosciences Inc.Day Trade & Capital Protection Trade Alerts - Newser
Visual analytics tools that track Akoya Biosciences Inc. performanceJuly 2025 Snapshot & Entry and Exit Point Strategies - Newser
How to manage a losing position in Cellectar Biosciences Inc.Weekly Market Report & High Accuracy Investment Signals - Newser
How sentiment analysis helps forecast Cellectar Biosciences Inc.2025 Retail Activity & High Accuracy Swing Entry Alerts - Newser
Finanzdaten der Cellectar Biosciences Inc-Aktie (CLRB)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cellectar Biosciences Inc-Aktie (CLRB) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod | Chief Operating Officer |
Jul 02 '25 |
Buy |
4.99 |
10,000 |
49,900 |
12,768 |
| Kolean Chad J | Chief Financial Officer |
Jul 02 '25 |
Buy |
4.99 |
5,000 |
24,950 |
6,418 |
| Longcor Jarrod | Chief Operating Officer |
Jan 10 '25 |
Buy |
0.28 |
30,000 |
8,400 |
83,141 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):